Thermo Fisher (TMO), Chevron (CVX) Rose While Otis, Exxon (XOM) Stabilized

Thermo Fisher Science Inc. (TMO) increased to $515.47, up +1.13 percent. The U.S. laboratory equipment company is losing ground on Wall Street before the stock market, while the company, due in part to the sales of Covid-19-related products, posted higher than anticipated quarterly revenue and earnings. The quarter’s adjusted EPS was $7.09, relative to a consensus of $6.86 and $3.55 a year ago. For the three months ended December, sales amounted to $10.55 billion, relative to a consensus of $10.3 billion and $6.83 billion the year before. Net earnings more than doubled to $2.5 billion per share and $6.24 while the adjusted EPS doubled. For the year, earnings climbed 26 percent to $32.2 billion, up 58 percent to $19.55 for an adjusted EPS.

Otis Worldwide Corporation (OTIS) almost steady at -0.15% to $64.55. Better-than-expected fourth-quarter results were announced by the elevator and escalator manufacturer. Net income was $251 million, or 58 cents a share, compared with $218 million a year ago and 50 cents per share. Adjusted earnings per share are 66 cents except for products, compared with 47 cents a year ago and 59 cents on the FactSet consensus. From a consensus of $3.36 billion, sales rose more than 4% year-on-year to $3.49 billion. The company predicts an adjusted EPS range from $2.67 to $2.77, with sales between $13.3 billion and $13.6 billion, for the fiscal year 2021, and after this return to growth. The consensus was $2.62 EPS and billings of $13.2 billion.

At +0.18% to $44.92, Exxon Mobil Corporation (XOM) remained steady, while Chevron Corporation (CVX) climbed +1.42% to $86.41. Last year, the Wall Street Journal said, the two U.S. oil colossuses had tentative talks on a possible merger. However, both companies suggested that these talks were only an effort and that there was actually no deal in place.


Please enter your comment!
Please enter your name here